Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
Background: Identification of risk factors for the development of hepatocellular carcinoma (HCC) is important for HCC surveillance in chronic hepatitis B virus (HBV) infection. Our aim was to study the independent risk factors and effect of HBV genotypes on HCC development in a prospective longitudi...
Saved in:
Published in: | Gut Vol. 53; no. 10; pp. 1494 - 1498 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
BMJ Publishing Group Ltd and British Society of Gastroenterology
01-10-2004
BMJ BMJ Publishing Group LTD Copyright 2004 by Gut |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Identification of risk factors for the development of hepatocellular carcinoma (HCC) is important for HCC surveillance in chronic hepatitis B virus (HBV) infection. Our aim was to study the independent risk factors and effect of HBV genotypes on HCC development in a prospective longitudinal cohort of chronic hepatitis B patients. Patients and methods: Chronic hepatitis B patients recruited since 1997 were prospectively followed up for the development of HCC. HCC was diagnosed by a combination of α fetoprotein, imaging, and histology. Liver cirrhosis was defined as ultrasonic features of cirrhosis together with hypersplenism, ascites, varices, and/or encephalopathy. Results: In total, 426 patients were followed up for 1664 person years; median 225 (range 12–295) weeks. Forty nine (11%) patients had underlying clinical liver cirrhosis. A total of 242 (57%) and 179 (42%) patients had HBV genotypes C and B, respectively. Twenty five patients developed HCC in a median follow up of 121 (range 14–236) weeks. The overall incidence of HCC was 1502 cases per 100 000 person years. On multivariate analysis, clinical liver cirrhosis and HBV genotype C infection were independently associated with HCC development, with an adjusted relative risk of 10.24 (95% confidence interval (CI) 4.39–23.89; p<0.001) and 2.84 (95% CI 1.05–7.72; p = 0.040), respectively. Patient age, sex, hepatitis B e antigen (HBeAg) status, alanine aminotransferase (ALT) levels, and basal core promoter mutations did not predict HCC development. Patients infected with HBV genotype C tended to have persistently positive HBeAg or fluctuating HBeAg status and higher ALT levels during the follow up period. Conclusion: Genotype C HBV infection is an independent risk factor for HCC development in addition to liver cirrhosis. |
---|---|
Bibliography: | href:gutjnl-53-1494.pdf istex:2EC3ADA5DD9D68E29E049FDE120757C3E6BF7501 PMID:15361502 local:0531494 ark:/67375/NVC-FGHSFWTS-X Correspondence to: Dr H L-Y Chan Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, 30–32 Ngan Shing St, Shatin, Hong Kong, China; hlychan@cuhk.edu.hk ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Dr H L-Y Chan Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, 30–32 Ngan Shing St, Shatin, Hong Kong, China; hlychan@cuhk.edu.hk |
ISSN: | 0017-5749 1468-3288 1458-3288 |
DOI: | 10.1136/gut.2003.033324 |